Okadaic acid treatment induces DNA adduct formation in BHK21 C13 fibroblasts and HESV keratinocytes

Mutation Research - Environmental Mutagenesis and Related Subjects

Volumn 361, Issue 2-3, 1996, Pages 133-141

  Fessard, Valérie ^a   Grosse, Yann ^b   Pfohl Leszkowicz, Annie ^b   Puiseux Dao, Simone ^c  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c CEMATMA   (France)

Author keywords

32P postlabelling; Genotoxicity; Okadaic acid

Indexed keywords

OKADAIC ACID;

ANIMAL CELL; ARTICLE; CELL STRAIN BHK; CONTROLLED STUDY; DNA ADDUCT; DOSE RESPONSE; FIBROBLAST; GENOTOXICITY; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0030581766     PISSN: 01651161     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1161(96)90248-4     Document Type: Article

References (42)

1. Aonuma S., Ushijima T., Nakayasu M., Shima H., Sugimura T., Nagao M. Mutation induction by okadaic acid, a protein phosphatase inhibitor, in CHL cells, but not in S. typhimurium. Mutation Res. 250:1991;375-381.
2. Aune T. Toxicity of marine and freshwater algal biotoxins towards freshly prepared hepatocytes. Natori S., Hashimoto K., Ueno Y. Mycotoxins and Phycotoxins. 1989;461-468 Elsevier, Amsterdam.
3. Aune T., Yasumoto T., Engeland E. Light and scanning electron microscopic studies on effects of marine algal toxins toward freshly prepared hepatocytes. J. Toxicol. Environ. Health. 34:1991;1-9.
4. Berghard A., Gradin K., et al. Cross-coupling of signal transduction pathways: the dioxin receptor mediates induction of cytochrome P450 1A1 expression via a protein kinase C-dependent mechanism. Mol. Cell. Biol. 13:1993;677-689.
5. Bøe R., Gjertsen B.T., Vintermyr O.K., Houge G., Lanotte M., Doskeland S.O. The protein phosphate inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells. Exp. Cell Res. 195:1991;237-246.
6. Diogène G., Fessard V., Dubreuil A., Puiseux-Dao S. Comparative studies of the actin cytoskeleton response to maitotoxin and okadaic acid. Toxic. Vitro. 9:1995;1-10.
7. Edebo L., Lange S., Li X.P., Allenmark S. Toxic mussels and okadaic acid induce rapid hypersecretion in the rat small intestine. Acta Pathol. Microbiol. Scand. 96:1988;1029-1035.
8. Fessard V., Pfohl-Leszkowicz A., Puiseux-Dao S. Okadaic acid treatment induces DNA adduct formation in BHK21 C13 fibroblasts and HESV keratinocytes. Cell. Biol. Toxicol. 11:1995;203.
9. Fujiki H. Is the inhibition of protein phosphatase 1 and 2A activities a general mechanism of tumor promotion in human cancer development? Mol. Carcinogen. 5:1992;91-94.
10. Fujiki H., Suganuma M. Tumor promotion by inhibitors of protein phosphatases and 2A: the okadaic acid class of compounds. Adv. Cancer Res. 61:1993;143-194.
11. Fujiki H., Suganuma M., Suguri H., Yoshizawa S., Ojika M., Wakamatsu K., Yamada K., Sugimura T. Induction of ornithine decarboxylase activity in mouse skin by a possible tumor promoter, okadaic acid. Proc. Jap. Acad., Ser. B. 63:1987;51-53.
12. Ghosh S., Paweletz N. Okadaic acid inhibits sister chromatid separation in mammalian cells. Exp. Cell Res. 200:1992a;215-217.
13. Ghosh S., Paweletz N. Localization of chromatin in `persitent' nucleoli in okadaic acid treated HeLa cells. Cell Biol. Intern. Rep. 16:1992b;475-480.
14. Hallegraeff G.M. A review of harmful algal blooms and their apparent global increase. Phycologia. 32:1993;79-99.
15. Hutchinson F. Use of data from bacteria to interpret data on DNA damage processing in mammalian cells. Mutation Res. 220:1989;73-82.
16. 2/M depending on dose. J. Cell. Physiol. 150:1992;484-492.
17. Ito E., Terao K. Injury and recovery process of intestine caused by okadaic acid related andcompounds. Natural Toxins. 2:1994;371-377.
18. Katoh F., Fitzgerald D.J., Giroldi L., Fujiki H., Sugimura T., Yamasaki H. Okadaic acid and phorbol esters: Comparative effects of these tumor promoters on cell transformation, intercellular communication and differentiation in vitro. Jpn. J. Cancer Res. 81:1990;590-597.
19. Kiguchi K., Giometti C., Chubb C.H., Fujiki H., Huberman E. Differentiation induction in human breast tumor cells by okadaic acid and related inhibitors of protein phosphatases 1 and 2A. Biochem. Biophys. Res. Commun. 189:1992;1261-1267.
20. Kuczuk M.H., Benson P.M., Heath H., Hayes W. Evaluation of the mutagenic potential of mycotoxins using Salmonella typhimurium and Saccharomyces cerevisiae. Mutation Res. 53:1978;11-20.
21. Kumagai M., Yanagi T., Murata M., Yasumoto T., Kat M., Lassus P., Rodriguez-Vasquez J.A. Okadaic acid as the causative toxin of diarrhetic shellfish poisoning in Europe. Agric. Biol. Chem. 50:1986;2853-2857.
22. Lange S., Andersson G.L., Jennishe E., Lonnroth I., Li X.P., Edebo L. Okadaic acid produces drastic histophathologic changes of the rat intestinal mucosa and with concomitant hypersection. Granéli E., Sundstrom B., Edler L., Anderson D.M. Toxic Marine Phytoplankton. 1990;356-361 Elsevier Science Inc. New York.
23. Mellgren G., Vintermyr O.K., Bøe R., Doskeland S.O. Hepatocyte DNA replication is abolished by inhibitors selecting protein phosphatase 2A rather than phosphatase 1. Exp. Cell Res. 205:1993;293-301.
24. Miller E.C. Some current perspective on chemical carcinogenesis in humans and experimental animals. Cancer Res. 38:1978;1479-1496.
25. Parke D.V., Ioannides C., et al. The role of the cytochrome P450 in the detoxication and activation of drugs and other chemicals. Can. J. Physiol. Pharmacol. 69:1991;537-549.
26. Pfohl-Leszkowicz A., Chakor K., Creppy E.E., Dirheimer G. DNA-adducts formation and variation of DNA-methylation after treatment of mice with ochratoxine A. Castegnaro M., Plestina R., Dirheimer G., Chernozemsky I.N., Bartsch H. Mycotoxins, Endemic and Urinary Tracts Tumors. Vol 115:1991;245-253 IARC Scientific Public, Lyon.
27. Pfohl-Leszkowicz A., Grosse Y., Kané A., Creppy E.E., Dirheimer G. Differential DNA adduct formation and disappearance in three mice tissues after treatment by the mycotoxin, ochratoxin A. Mutation Res. 289:1993;265-273.
28. 32P-postlabelling test for damage. Proc. Natl. Acad. Sci. USA. 78:1981;6126-6129.
29. 32P-postlabelling test for structurally diverse DNA-adducts. Carcinogenesis. 7:1986;1543-1551.
30. Rieber M.S., Rieber M. Accessibility to DNA in carcinoma chromatin is promoted by nanomolar okadaic acid: effect on AT-rich DNA binding proteins. Cancer Res. 52:1992;6397-6399.
31. Rogers C.G., Heroux-Metcalf C., Langlois I. Evaluation of cytotoxicity and genotoxicity of okadaic acid, a nonphorbol ester type tumor promoter, in V79 chinese hamster lung cells. Toxic. Vitro. 8:1994;269-276.
32. Suganuma M., Fujiki H., Suguri H., Yoshizawa S., Hirota M., Nakayasu M., Ojika M., Wakamatsu K., Yamada K., Sugimura T. Okadaic acid: an additional non-phorbol 12-tetradecanoate-13-acetate type tumor promoter. Proc. Natl. Acad. Sci. USA. 85:1988;1768-1771.
33. Suganuma M., Tatematsu M., Yatsunami J., Yoshizawa S., Okabe S., Uemura D., Fujiki H. An alternative theory of tissue specificity by tumor promotion of okadaic acid in glandular stomach of SD rats. Carcinogenesis. 13:1992;1841-1845.
34. Sun T.S.C., Stahr H.M. Evaluation and application of a bioluminescent bacterial genotoxicity test. J. AOAC Intern. 76:1993;893-898.
35. Terao K., Ito E., Yanagi T., Yasumoto T. Histopathological studies on experimental marine toxin poisoning. I. Ultrastructural changes in the small intestine and liver of suckling mice induced by dinophysistoxin-1 and pectenotoxin-1. Toxicon. 24:1986;1141-1151.
36. Tohda H., Nagao M., Sugimura T., Oikawa A. Okadaic acid, a protein phosphatase inhibitor, induces sister-chromatid exchanges depending on the presence of bromodeoxyuridine. Mutation Res. 289:1993;275-280.
37. Vandré D.D., Wills V.L. Inhibition of mitosis by okadaic acid: possible involvement of a protein phosphatase 2A in the transition from metaphase to anaphase. J. Cell Sci. 101:1992;79-91.
38. Wehner F.C., Thiel P.G., Van Rensburg S.J., Demasius I.P. Mutagenicity to Salmonella typhimurium of some Aspergillus and Penicilium toxins. Mutation Res. 58:1978;193-203.
39. Yamashita K., Yasuda H., Pines J., Yasumoto K., Nishitani H., Ohtsubo M., Hunter T., Sugimura T., Nishimoto T. Okadaic acid, a potent inhibitor of type 1 and type 2A protein phosphatases, activates cdc2/H1 kinase and transiently induces a premature mitosis- like state in BHK21 cells. EMBO J. 9:1990;4331-4338.
40. Yuasa H., Yoshida K., Iwata H., Nakanishi H., Suganuma M., Tatematsu M. Increase of labelling indices in gastrointestinal mucosae of mice and rats by compounds of the okadaic acid type. J. Cancer Res. Clin. Oncol. 120:1994;208-212.
41. Zheng B., Woo C.F., Kuo J.F. Mitotic arrest and enhanced nuclear protein phosphorylatrion in human leukemia K562 cells by okadaic acid, a potent protein phosphatase inhibitor and tumor promoter. J. Biol. Chem. 266:1991;10031-10034.
42. Zheng B., Chambers T.C., Raynor R.L., Markham P.N., Gebel H.M., Vogler W.R., Kuo J.F. Human leukemia K562 cell mutant (K562/OA200) selected for resistance to okadaic acid (protein phosphatase inhibitor) lacks protein kinase C-e, exhibits multidrug resistance phenotype, and expresses drug pump P-glycoprotein. J. Biol. Chem. 269:1994;12332-12338.